logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Rhinitis Allergic Perennial

    FiltersReset Filters
    9 results

    • carbinoxamine maleate

      (CARBINOXAMINE MALEATE)
      BluCrest Pharmaceuticals, LLC
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations, dermatographism, and as an adjunctive therapy for anaphylactic reactions and allergic reactions to blood or plasma.

    • cetirizine hydrochloride

      (Cetirizine hydrochloride)
      Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.
      Usage: Cetirizine hydrochloride oral solution is indicated for relieving symptoms of perennial allergic rhinitis and treating uncomplicated skin manifestations of chronic idiopathic urticaria in children aged 6 months to 23 months. It effectively addresses sneezing, runny nose, and hives, reducing their occurrence and severity.

    • cetirizine hydrochloride oral solution

      (Cetirizine Hydrochloride Oral Solution)
      APOZEAL PHARMACEUTICALS INC
      Usage: Cetirizine Hydrochloride Oral Solution is indicated for relieving symptoms of perennial allergic rhinitis in children 6 to 23 months and treating chronic idiopathic urticaria in children 6 months to 5 years, effectively reducing sneezing, nasal and ocular symptoms, and hive-related discomfort.

    • desloratadine

      (DESLORATADINE)
      Lupin Pharmaceuticals, Inc.
      Usage: Desloratadine tablets are indicated for relieving nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis in patients aged 12 and older.

    • dexamethasone

      (dexamethasone)
      Amneal Pharmaceuticals NY LLC
      Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.

    • ipratropium bromide

      (Ipratropium Bromide)
      Apotex Corp.
      Usage: Ipratropium bromide nasal solution, 0.03% is used to relieve rhinorrhea in adults and children aged 6 and older with allergic and nonallergic perennial rhinitis. It does not address nasal congestion, sneezing, or postnasal drip.

    • levocetirizine dihydrochloride

      (Levocetirizine dihydrochloride)
      Padagis Israel Pharmaceuticals Ltd
      Usage: Levocetirizine dihydrochloride is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months and older.

    • levocetirizine dihydrochloride

      (Levocetirizine Dihydrochloride)
      Chartwell RX, LLC
      Usage: Levocetirizine dihydrochloride oral solution is indicated for relief of perennial allergic rhinitis symptoms in children aged 6 months to 2 years, and for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months and older.

    • rayos

      (prednisone)
      Horizon Therapeutics USA, Inc.
      Usage: RAYOS is indicated for severe allergic conditions, various dermatologic and endocrine diseases, gastrointestinal disorders (like Crohn's and ulcerative colitis), hematologic issues, neoplasms, nervous system conditions (such as multiple sclerosis), certain ophthalmic diseases, organ transplant rejection, pulmonary disorders, renal conditions, rheumatologic ailments, and specific infectious diseases.